Idaho - Boise, Moscow, Idaho Falls Indian Community - IdahoIndian.com
| | | | | | | | | | | |
 


 

Parkinson's disease may up schizophrenia risk: Study

Finland,Health/Medicine

Author : Indo Asian News Service

International, Health/Medicine, National, Finland Read Latest News and Articles

Share With Your Friends



Add an Article

View All Contributions

Add To My Favorite

Add A Picture

Helsinki, Jan 16 (IANS) Patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life.

The study indicates that the increased risk may be due to alterations in the brain's dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia.

"According to our results, a previously diagnosed psychotic disorder or schizophrenia may be one factor that increases the risk of Parkinson's disease later in life," said researcher Tomi Kuusimäki from the University of Turku in Finland.

For the study, published in the journal Movement Disorders, the researchers examined the occurrences of previously diagnosed psychotic disorders and schizophrenia in over 25,000 Finnish Parkinson's disease patients treated between 1996 and 2019.

In the study, patients with Parkinson's disease were noted to have previously diagnosed psychotic disorders and schizophrenia more often than the control patients of the same age not diagnosed with Parkinson's disease.

Parkinson's disease is currently the most rapidly increasing neurological disorder in the world. It is a neurodegenerative disorder that is most common in patients over 60 years of age. The cardinal motor symptoms include shaking, stiffness and slowness of movement.

In Parkinson's disease, the neurons located in the substantia nigra in the midbrain slowly degenerate, which leads to deficiency in a neurotransmitter called dopamine.

As for schizophrenia, the dopamine level increases in some parts of the brain. In addition, the pharmacotherapies used in the primary treatment of Parkinson's disease and schizophrenia appear to have contrasting mechanisms of action.

Parkinson's disease symptoms can be alleviated with dopamine receptor agonists, whereas schizophrenia is commonly treated with dopamine receptor antagonists.

--IANS

vc/in


Copyright and Disclaimer: All news and images appearing in our news section, search engines and social media are provided by IANS. If you face any issues related to the content/images, please contact our news service provider directly. We are not liable/responsible for any content/images related to the news service provider.


Latest News

View More News


More News Articles

IPL 2024: 'They are just one knock away,' PBKS' Sanjay Bangar backs top-order to fire soon

Salman Khan case: 2 shooters nabbed from Pakistan-bordering Kachchh, sent to 10-day police custody (Lead)

IPL 2024: Ashwin back from injury as Rajasthan Royals opt to bowl against Kolkata Knight Riders

Salman case: 2 shooters nabbed from Pakistan-bordering Kachchh, sent to 10 days police custody (Lead)

IPL 2024: Ashwin back from injury as Rajasthan Royals opt to bowl first against Kolkata Knight Riders